We offer individualized 1:1 therapy as well as social skills groups. Families come to Play Lab ABA to work on Social, communication, and daily living skills. We utilize a trauma-informed approach to ...

EIK1001 achieves 63.1% response rate in untreated stage 4 lung cancer, with strong disease control across histology subtypes ...

Wilmington treatment provider celebrates a decade of growth, clinical standards, and gender-specific care through The ...

Israel’s Health Ministry has authorized the world’s first national clinical trial combining MDMA and psilocybin to treat treatment-resistant post-traumatic stress disorder. Both compounds will be ...

Paradigm Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing innovative treatments for rare ...

Entrada's ENTR-601-45 met its Phase I/II safety endpoint at 5 mg/kg in DMD patients, showing modest dystrophin gains. Read ...

Clinical trials are a key driver of biotech stocks. Every new therapy must pass through a series of testing, Phase 1, Phase 2, and Phase 3, before it is approved and available to patients. Each phase ...

Queensland Director of Public Prosecutions guidelines no longer reference eye movement desensitisation and reprocessing (EMDR) therapy. A Sunshine Coast woman had an investigation into alleged child ...

Patrick Clancy says a therapy treatment he used to cope with the trauma of losing his children worked “like a miracle.” Speaking in extended clips from the latest episode of “60 Minutes,” the ...

Eli Lilly has stopped showing competitors its opening moves. As recently as February, the pharma giant publicly listed a substantial roster of drugs in phase 1 development. Lilly’s select-pipeline ...

The finalized pilot program will pair drug sponsors with selected “qualified research institutions” or QRIs, which can include contract research organizations, academic medical centers, regulatory ...

As its world-lead­ing GLP-1 earns more than any oth­er med­i­cine — and its mar­ket cap eclipses all oth­er health­care com­pa­nies — Eli Lil­ly has de­cid­ed to stop dis­clos­ing its Phase 1 pipeline ...